GGHC
ETRM

Gilder Gagnon Howe & Co’s EnteroMedics Inc. ETRM Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-78
Closed -$148K – 338
2014
Q1 		$148K Sell
78
-3
-4% -$7.1K ﹤0.01% 252
2013
Q4 		$173K Buy
+81
New +$131K ﹤0.01% 240

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Gilder Gagnon Howe & Co's ETRM Position: Q2 2014 in Review

Gilder Gagnon Howe & Co sold out of EnteroMedics Inc. (ETRM) in Q2 2014, closing a stake of 78 shares — an estimated $148K sold.

Gilder Gagnon Howe & Co first reported a position in ETRM in Q4 2013 and held it in 2 quarters. The position peaked at $173K in Q4 2013. 56 funds tracked by Wall St. Rank hold ETRM as of Q2 2014.

  • Gilder Gagnon Howe & Co reported no remaining EnteroMedics Inc. position as of Q2 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 78 EnteroMedics Inc. shares in Q2 2014, an estimated $148K.
  • Gilder Gagnon Howe & Co first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's EnteroMedics Inc. position peaked at $173K in Q4 2013.
  • 56 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2014, filed 1 Aug 2014.